BG60262B2 - Process for the preparation of substituted bicyclic compounds - Google Patents

Process for the preparation of substituted bicyclic compounds

Info

Publication number
BG60262B2
BG60262B2 BG70749A BG7074985A BG60262B2 BG 60262 B2 BG60262 B2 BG 60262B2 BG 70749 A BG70749 A BG 70749A BG 7074985 A BG7074985 A BG 7074985A BG 60262 B2 BG60262 B2 BG 60262B2
Authority
BG
Bulgaria
Prior art keywords
salt
preparation
stereoisomers
formula
compounds
Prior art date
Application number
BG70749A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG60262B1 (bg
Inventor
Leslie Browne
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BG60262B1 publication Critical patent/BG60262B1/bg
Publication of BG60262B2 publication Critical patent/BG60262B2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG70749A 1984-06-20 1985-06-19 Process for the preparation of substituted bicyclic compounds BG60262B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/622,421 US4617307A (en) 1984-06-20 1984-06-20 Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors

Publications (2)

Publication Number Publication Date
BG60262B1 BG60262B1 (bg) 1994-03-31
BG60262B2 true BG60262B2 (en) 1994-03-31

Family

ID=24494112

Family Applications (7)

Application Number Title Priority Date Filing Date
BG70749A BG60262B2 (en) 1984-06-20 1985-06-19 Process for the preparation of substituted bicyclic compounds
BG097011A BG60307B2 (en) 1984-06-20 1992-10-22 Method for obtaining of substituted two-ring compounds
BG097012A Expired - Lifetime BG60352B2 (bg) 1984-06-20 1992-10-22 Метод за получаване на тетрахидропроизводни на заместени двупръстенни съединения
BG097010A BG60306B2 (bg) 1984-06-20 1992-10-22 Метод за получаване на заместени двупръстенни съединения
BG097009A BG60305B2 (bg) 1984-06-20 1992-10-22 Метод за получаване на заместени двупръстенни съединения
BG097013A BG60353B2 (bg) 1984-06-20 1992-10-22 Метод за получаване на заместени двупръстенни съединения
BG098213A BG60402B2 (bg) 1984-06-20 1993-11-11 Заместени бициклични съединения

Family Applications After (6)

Application Number Title Priority Date Filing Date
BG097011A BG60307B2 (en) 1984-06-20 1992-10-22 Method for obtaining of substituted two-ring compounds
BG097012A Expired - Lifetime BG60352B2 (bg) 1984-06-20 1992-10-22 Метод за получаване на тетрахидропроизводни на заместени двупръстенни съединения
BG097010A BG60306B2 (bg) 1984-06-20 1992-10-22 Метод за получаване на заместени двупръстенни съединения
BG097009A BG60305B2 (bg) 1984-06-20 1992-10-22 Метод за получаване на заместени двупръстенни съединения
BG097013A BG60353B2 (bg) 1984-06-20 1992-10-22 Метод за получаване на заместени двупръстенни съединения
BG098213A BG60402B2 (bg) 1984-06-20 1993-11-11 Заместени бициклични съединения

Country Status (31)

Country Link
US (1) US4617307A (zh)
EP (1) EP0165904B1 (zh)
JP (1) JPS6112688A (zh)
KR (1) KR900008566B1 (zh)
AT (1) ATE62415T1 (zh)
AU (1) AU589565B2 (zh)
BG (7) BG60262B2 (zh)
CA (1) CA1276633C (zh)
CS (1) CS268672B2 (zh)
CY (1) CY1750A (zh)
DD (1) DD237510A5 (zh)
DE (1) DE3582452D1 (zh)
DK (1) DK170302B1 (zh)
DZ (1) DZ799A1 (zh)
ES (6) ES8702406A1 (zh)
FI (1) FI80694C (zh)
GR (1) GR851487B (zh)
HK (1) HK23494A (zh)
HU (1) HU202529B (zh)
IE (1) IE58070B1 (zh)
IL (1) IL75546A (zh)
MA (1) MA20459A1 (zh)
MX (1) MX9203369A (zh)
NO (1) NO162467C (zh)
NZ (1) NZ212483A (zh)
PH (1) PH23390A (zh)
PL (6) PL145105B1 (zh)
PT (1) PT80661B (zh)
RO (1) RO92583A (zh)
SU (6) SU1433413A3 (zh)
ZA (1) ZA854615B (zh)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728645A (en) * 1982-12-21 1988-03-01 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors
US5428160A (en) * 1982-12-21 1995-06-27 Ciba-Geigy Corporation Substituted imidazo[5-a]pyridine derviatives and other substituted bicyclic derivatives
US4889861A (en) * 1982-12-21 1989-12-26 Ciba-Geigy Corp. Substituted imidazo[1,5-a]pyridine derivatives and other substituted bicyclic derivatives and their use as aromatase inhibitors
GB8510541D0 (en) * 1985-04-25 1985-05-30 Wyeth John & Brother Ltd Heterocyclic compounds
US5171858A (en) * 1985-06-05 1992-12-15 Schering A.G. Preparation of certain 5,6-dihydro-8-phenyl-imidazo[1,5-a]pyridines
US4937250A (en) * 1988-03-07 1990-06-26 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4797411A (en) * 1986-07-18 1989-01-10 Farmitalia Carlo Erba S.P.A. Cycloalkyl-substituted 4-pyridyl derivatives and use as aromatase inhibitors
GB8820730D0 (en) * 1988-09-02 1988-10-05 Erba Carlo Spa Substituted 5 6 7 8-tetrahydroimidazo/1.5-a/pyridines & process for their preparation
US5057521A (en) * 1988-10-26 1991-10-15 Ciba-Geigy Corporation Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
CA2026792A1 (en) * 1989-11-01 1991-05-02 Michael N. Greco (6,7-dihydro-5h-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1h-benzotriazole derivatives
US5066656A (en) * 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
MTP1076B (en) * 1990-01-12 1991-09-30 Ciba Geigy Ag Hemihydrate
US5162337A (en) * 1990-10-05 1992-11-10 Merck & Co., Inc. Animal growth promotion
CA2066369A1 (en) * 1991-04-19 1992-10-20 Alex Elbrecht Control of sex differentiation in fish
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
JPH05176659A (ja) * 1991-04-26 1993-07-20 Merck & Co Inc 家禽における雌性表現型を転換するために抗ミュラー管ホルモンを単独またはアロマターゼ阻害剤と組合せて使用する方法
WO1995028156A1 (en) * 1994-04-14 1995-10-26 Sepracor, Inc. Treating estrogen-dependent diseases with (-)-fadrozole
AU682947B2 (en) * 1994-05-27 1997-10-23 Mochida Pharmaceutical Co., Ltd. Novel azolyl methyl phenyl derivatives having aromatase inhibitory activity
DE4432106A1 (de) * 1994-09-09 1996-03-14 Hoechst Ag Mit Heterocyclen-N-Oxid-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum, sie enthaltendes Medikament sowie Zwischenprodukte zu ihrer Herstellung
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US8168616B1 (en) 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
BR0313081A (pt) * 2002-07-30 2005-07-12 Novartis Ag Combinação de um inibidor de aromatase com um bisfosfanato
ATE335744T1 (de) * 2002-08-07 2006-09-15 Novartis Pharma Gmbh Organische verbindungen als mittel zur behandlung von aldosteronbedingten zuständen
PT1565463E (pt) * 2002-11-18 2008-09-10 Novartis Ag Derivados de imidazo[1,5-a]piridina e métodos para tratar doenças mediadas pela aldosterona
WO2005007627A1 (ja) * 2003-07-18 2005-01-27 Nihon Nohyaku Co., Ltd. フェニルピリジン誘導体、その中間体及びこれを有効成分とする除草剤
GB0327839D0 (en) 2003-12-01 2003-12-31 Novartis Ag Organic compounds
BRPI0508880A (pt) 2004-03-17 2007-09-04 Novartis Ag uso de compostos orgánicos
AR049388A1 (es) * 2004-05-28 2006-07-26 Speedel Experimenta Ag Heterociclos como inhibidores de aldosterona sintasa
EP1765777A2 (en) * 2004-05-28 2007-03-28 Speedel Experimenta AG Bicyclic, nitrogen-containing heterocycles as aromatase inhibitors
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
EP1842543A1 (en) 2006-04-05 2007-10-10 Speedel Pharma AG Pharmaceutical composition coprising an aldosterone synthase inhibitor and a mineralcorticoid receptor antagonist
KR20090020580A (ko) * 2006-05-26 2009-02-26 노파르티스 아게 알도스테론 신타제 및/또는 11β-히드록실라제 억제제
CA2657258A1 (en) 2006-07-20 2008-01-24 Novartis Ag Amino-piperidine derivatives as cetp inhibitors
RU2009110442A (ru) * 2006-08-25 2010-09-27 Новартис АГ (CH) Конденсированные производные имидазола для лечения нарушений, опосредованных альдостеронсинтазой, и/или 11-бета-гидроксилазой, и/или ароматазой
US20090325936A1 (en) * 2006-12-20 2009-12-31 Bilodeau Mark T Imidazopyridine analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
PE20090982A1 (es) 2007-11-05 2009-08-13 Novartis Ag Derivados de piperidina como inhibidores de la proteina de transferencia de colesteril-ester (cetp)
US8759365B2 (en) 2007-12-03 2014-06-24 Novartis Ag Organic compounds
EP2095819A1 (en) * 2008-02-28 2009-09-02 Maastricht University N-benzyl imidazole derivatives and their use as aldosterone synthase inhibitors
EA201101672A1 (ru) 2009-05-28 2012-06-29 Новартис Аг Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
AU2010251967B9 (en) 2009-05-28 2014-04-03 Novartis Ag Substituted aminopropionic derivatives as neprilysin inhibitors
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
US8877815B2 (en) 2010-11-16 2014-11-04 Novartis Ag Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
US8673974B2 (en) 2010-11-16 2014-03-18 Novartis Ag Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
TWI518073B (zh) * 2011-06-14 2016-01-21 美國禮來大藥廠 醛固酮合成酶抑制劑
CA2841117A1 (en) 2011-07-08 2013-01-17 Novartis Ag 1,2-disubstituted-4-benzylamino-piperidinyl derivatives as cetp inhibitors useful for the treatment of atherosclerosis in high triglyceride subjects
JP5749410B2 (ja) 2012-01-17 2015-07-15 ノバルティス アーゲー ジヒドロピロロ［１，２−ｃ］イミダゾリルアルドステロンシンターゼまたはアロマターゼ阻害薬の新たな形態および塩
UY35144A (es) 2012-11-20 2014-06-30 Novartis Ag Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca
PE20151666A1 (es) 2013-02-14 2015-11-19 Novartis Ag Derivados sustituidos del acido bisfenil butanoico fosfonico como inhibidores de la nep
CN105612172A (zh) 2013-07-25 2016-05-25 诺华股份有限公司 用于治疗心力衰竭的环状多肽
PE20160991A1 (es) 2013-07-25 2016-10-15 Novartis Ag Bioconjugados de polipeptidos de apelina sintetica
BR112017014194A2 (pt) 2015-01-23 2018-01-09 Novartis Ag conjugados de ácido graxo de apelina sintéticos com meia-vida melhorada
MX2017009839A (es) * 2015-01-29 2017-11-02 Novartis Ag Proceso para la produccion de derivados de imidazolo condensados.
GB201511790D0 (en) * 2015-07-06 2015-08-19 Iomet Pharma Ltd Pharmaceutical compound
JP2016074729A (ja) * 2015-12-31 2016-05-12 国立大学法人 千葉大学 イミダゾリウム塩及びそれを用いた不斉合成触媒並びにイミダゾリウム塩の製造方法
JOP20190086A1 (ar) 2016-10-21 2019-04-18 Novartis Ag مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب
WO2018078049A1 (en) 2016-10-27 2018-05-03 Damian Pharma Ag Aldosterone synthase inhibitor
KR20230037680A (ko) * 2016-10-27 2023-03-16 다미안 파르마 에이쥐 알도스테론 합성효소 저해제
UY38072A (es) 2018-02-07 2019-10-01 Novartis Ag Compuestos derivados de éster butanoico sustituido con bisfenilo como inhibidores de nep, composiciones y combinaciones de los mismos
IL314302A (en) 2018-05-03 2024-09-01 Damian Pharma Ag R-Pedrazole for use in the treatment of aldosteronism
UY38485A (es) 2018-11-27 2020-06-30 Novartis Ag Compuestos tetrámeros cíclicos como inhibidores de proproteína convertasa subtilisina/kexina tipo 9 (pcsk9), método de tratamiento, uso y su preparación
CN113166204A (zh) 2018-11-27 2021-07-23 诺华股份有限公司 作为治疗代谢障碍的蛋白质原转换酶枯草杆菌蛋白酶/kexin 9型（PCSK9）抑制剂的环状肽
EP3887363A1 (en) 2018-11-27 2021-10-06 Novartis AG Cyclic pentamer compounds as proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibitors for the treatment of metabolic disorder
WO2023084449A1 (en) 2021-11-12 2023-05-19 Novartis Ag Diaminocyclopentylpyridine derivatives for the treatment of a disease or disorder

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5124517B1 (zh) * 1971-03-15 1976-07-24
FR2449689A1 (fr) * 1979-02-20 1980-09-19 Logeais Labor Jacques Nouveaux derives condenses de pyrrolidine ou de piperidine, leur procede de preparation et leurs applications en therapeutique
US4444775A (en) * 1981-06-22 1984-04-24 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridines
GB2101595B (en) * 1981-06-22 1985-05-30 Ciba Geigy Ag Substituted imidazo(1,5-a)pyridines, process for their manufacture, pharmaceutical preparations containing these compounds and their therapeutic application
US4361567A (en) * 1981-10-05 1982-11-30 Schering Corporation Treatment of peptic ulcer disease
US4409226A (en) * 1981-10-05 1983-10-11 Schering Corporation Imidazo[1,5-a]pyridines
US4470986A (en) * 1982-12-21 1984-09-11 Ciba-Geigy Corporation Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors
US4588732A (en) * 1982-12-21 1986-05-13 Ciba-Geigy Corporation Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors

Also Published As

Publication number Publication date
FI80694B (fi) 1990-03-30
NZ212483A (en) 1988-10-28
AU4385785A (en) 1986-01-02
BG60306B2 (bg) 1994-07-25
PL145814B1 (en) 1988-11-30
IL75546A0 (en) 1985-10-31
FI80694C (fi) 1990-07-10
BG60352B2 (bg) 1994-11-30
ES555538A0 (es) 1988-03-16
CY1750A (en) 1994-06-03
HUT37936A (en) 1986-03-28
EP0165904A2 (de) 1985-12-27
ES8801262A1 (es) 1987-12-16
FI852399A0 (fi) 1985-06-17
GR851487B (zh) 1985-11-25
KR900008566B1 (ko) 1990-11-24
SU1433413A3 (ru) 1988-10-23
PH23390A (en) 1989-07-26
ES8802155A1 (es) 1988-04-01
CS444985A2 (en) 1989-07-12
DK170302B1 (da) 1995-07-31
IL75546A (en) 1990-01-18
ES8800681A1 (es) 1987-11-16
HK23494A (en) 1994-03-25
ES555541A0 (es) 1987-11-16
ES8702406A1 (es) 1987-01-01
FI852399L (fi) 1985-12-21
SU1436879A3 (ru) 1988-11-07
DE3582452D1 (de) 1991-05-16
SU1482530A3 (ru) 1989-05-23
SU1443802A3 (ru) 1988-12-07
DK277685A (da) 1985-12-21
PL145087B1 (en) 1988-08-31
BG60307B2 (en) 1994-07-25
ES8802049A1 (es) 1988-03-16
PL254099A1 (en) 1986-09-09
PL145105B1 (en) 1988-08-31
BG60305B2 (bg) 1994-07-25
JPH047746B2 (zh) 1992-02-12
JPS6112688A (ja) 1986-01-21
IE58070B1 (en) 1993-06-30
SU1436880A3 (ru) 1988-11-07
EP0165904A3 (en) 1987-09-09
RO92583A (ro) 1987-11-30
US4617307A (en) 1986-10-14
IE851520L (en) 1985-12-20
KR860000299A (ko) 1986-01-27
PT80661B (en) 1987-05-04
SU1436878A3 (ru) 1988-11-07
AU589565B2 (en) 1989-10-19
NO162467B (no) 1989-09-25
PL145348B1 (en) 1988-09-30
PL145104B1 (en) 1988-08-31
DK277685D0 (da) 1985-06-19
BG60353B2 (bg) 1994-11-30
NO162467C (no) 1990-01-10
ES544344A0 (es) 1987-01-01
ES555539A0 (es) 1988-04-01
DZ799A1 (fr) 2004-09-13
ES555540A0 (es) 1987-12-16
EP0165904B1 (de) 1991-04-10
ZA854615B (en) 1986-02-26
PL145103B1 (en) 1988-08-31
ATE62415T1 (de) 1991-04-15
BG60402B2 (bg) 1995-02-28
BG60262B1 (bg) 1994-03-31
NO852474L (no) 1985-12-23
ES8802048A1 (es) 1988-03-16
ES555542A0 (es) 1988-03-16
HU202529B (en) 1991-03-28
CA1276633C (en) 1990-11-20
DD237510A5 (de) 1986-07-16
MX9203369A (es) 1992-09-01
CS268672B2 (en) 1990-04-11
PT80661A (en) 1985-07-01
MA20459A1 (fr) 1985-12-31

Similar Documents

Publication Publication Date Title
BG60262B2 (en) Process for the preparation of substituted bicyclic compounds
PT81542A (en) Process for the preparation of substituted imidazo derivatives and of pharmaceutical compositions containing the same
ATE38661T1 (de) Zwischenprodukt und verfahren zu dessen herstellung.
HUT41761A (en) Process for producing tricyclic aromatic compounds
ES8503685A1 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
HU199766B (en) Process for producing new bicyclic compounds of 5-lipoxygenaze inhibiting activity and pharmaceutical compositions containing them
ATE19773T1 (de) Nitroaliphatische verbindungen, verfahren zu deren herstellung und deren verwendung.
ES8502994A1 (es) Procedimiento para la obtencion de imidazo (1,5-a)piridinas
ZA848304B (en) 1,3-dioxan-4-ylalkenoic acids
EP0050671A4 (en) THIAZOLE (3,2-a) PYRIMIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THEM.
US3857854A (en) 6-phenyl-1h,4h-{8 1,2,4{9 oxadiazalo{8 4,3-2{9 {8 1,4{9 benzodiazepin-1-ones
DE3477781D1 (en) Spiro(indolo(1,7-ab)(1,5)benzodiazepine-2,4'-piperidines) and intermediates, a process for the preparation thereof and their use as medicaments
ES8707528A1 (es) Un procedimiento para preparar benzo (c)-1,5-naftiridinas
JPS5649385A (en) Novel s-triazolo- 1,5-a -pyrimidine derivative
ES8400434A1 (es) "un procedimiento para preparar 1,2-dihidropirido(3,4-b)pirazinas".
PT84005A (en) 6h-isoxazol]3,4-d"pyrazolo]3,4-b"pyridines a process and intermediates for their preparation and their use as medicaments
ES8105713A1 (es) Un procedimiento para la preparacion de los enatiomeros levogiro y dextrogiro de la 1-ciclopropil-metil-4-(3-metoxi-5h- dibenzo (a,d) ciclohepten-5-iliden) piperidina
HUT38920A (en) Process for producing anticonvulsive tetrahydro-1,2,4-oxadiazine-5-thion derivatives